Generation of a Surgical Field in the Left Lateral Decubitus Position
Sponsor
Shizuoka Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT04683601
Collaborator
(none)
154
56
Study Details
Study Description
Brief Summary
The generation of a good surgical field at the mid-lower mediastinum during thoracoscopic esophagectomy in the left lateral decubitus position is often complicated. The investigators developed a simple and useful technique for surgical field generation.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
154 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Generation of a Surgical Field at the Mid-lower Mediastinum for Thoracoscopic Esophagectomy in the Left Lateral Decubitus Position
Actual Study Start Date
:
Apr 1, 2015
Actual Primary Completion Date
:
Dec 1, 2019
Actual Study Completion Date
:
Dec 1, 2019
Outcome Measures
Primary Outcome Measures
- Completion rate of thoracoscopic esophagectomy [During surgery]
The rate of completion of thoracic esophagectomy with our method for the generation of surgical field in mid-lower mediastinum.
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients who underwent thoracoscopic esophageal resection from April 2015 to December 2019 in our hospital.
Exclusion Criteria:
- patients who underwent open thoracotomy
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Shizuoka Cancer Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Kenjiro Ishii,
Principal Investigator,
Shizuoka Cancer Center
ClinicalTrials.gov Identifier:
NCT04683601
Other Study ID Numbers:
- ShizuokaCC 2
First Posted:
Dec 24, 2020
Last Update Posted:
Dec 24, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kenjiro Ishii,
Principal Investigator,
Shizuoka Cancer Center
Additional relevant MeSH terms: